184 related articles for article (PubMed ID: 2777137)
1. Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease.
Wehmeier A; Scharf RE; Fricke S; Schneider W
Haemostasis; 1989; 19(5):251-9. PubMed ID: 2777137
[TBL] [Abstract][Full Text] [Related]
2. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
Wehmeier A; Daum I; Jamin H; Schneider W
Ann Hematol; 1991 Aug; 63(2):101-6. PubMed ID: 1912029
[TBL] [Abstract][Full Text] [Related]
3. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
Wehmeier A; Südhoff T; Meierkord F
Semin Thromb Hemost; 1997; 23(4):391-402. PubMed ID: 9263357
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders.
Wehmeier A; Fricke S; Scharf RE; Schneider W
Eur J Haematol; 1990 Oct; 45(4):191-7. PubMed ID: 2146144
[TBL] [Abstract][Full Text] [Related]
5. Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time.
Baker RI; Manoharan A
Eur J Haematol; 1988 Mar; 40(3):267-72. PubMed ID: 3356243
[TBL] [Abstract][Full Text] [Related]
6. Hemorrhagic and thrombotic complications in patients with myeloproliferative diseases.
Vignal CV; Lourenço DM; Noguti MA; Chauffaille Mde L; Kerbauy J
Sao Paulo Med J; 1997; 115(6):1575-9. PubMed ID: 9640794
[TBL] [Abstract][Full Text] [Related]
7. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
[TBL] [Abstract][Full Text] [Related]
8. Bleeding and thrombosis in the myeloproliferative disorders.
Schafer AI
Blood; 1984 Jul; 64(1):1-12. PubMed ID: 6375757
[TBL] [Abstract][Full Text] [Related]
9. [Platelet defects in chronic myeloproliferative disorders].
Raszeja-Specht A; Skibowska A; Kabata J; Hellmann A
Acta Haematol Pol; 1994; 25(3):253-60. PubMed ID: 7992598
[TBL] [Abstract][Full Text] [Related]
10. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand factor abnormalities in myeloproliferative disorders and other hematologic diseases: a retrospective analysis by a single institution.
Sánchez-Luceros A; Meschengieser SS; Woods AI; Blanco AN; Kempfer AC; Casais P; Salviú MJ; Lazzari MA
Haematologica; 2002 Mar; 87(3):264-70. PubMed ID: 11869938
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis of thrombotic and hemorrhagic complications in myeloproliferative and myelodysplastic syndromes].
Vlădăreanu AM; Popov V; Bumbea H; Ciufu C; Vasilache V; Petre A; Onisâi M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):14-9. PubMed ID: 21688554
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytosis and Thrombosis: Is There Really a Correlation?
Galvez C; Stein BL
Curr Hematol Malig Rep; 2020 Aug; 15(4):261-267. PubMed ID: 32399765
[TBL] [Abstract][Full Text] [Related]
15. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
16. [Thrombosis and platelet dysfunction in myeloproliferative neoplasms].
Mornet C; Galinat H; Mingant F; Ianotto JC; Lippert E
Rev Med Interne; 2020 May; 41(5):319-324. PubMed ID: 32008800
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients.
Grossi A; Rosseti S; Vannucchi AM; Rafanelli D; Ferrini PR
Clin Lab Haematol; 1988; 10(2):167-75. PubMed ID: 3416575
[TBL] [Abstract][Full Text] [Related]
18. [Platelet anomaly in an eosinophilic myelophroliferative syndrome].
Wautier JL; Dupuy E; Michel H; Caen JP
Nouv Presse Med; 1976 Mar; 5(11):704-6. PubMed ID: 1083506
[TBL] [Abstract][Full Text] [Related]
19. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
[No Abstract] [Full Text] [Related]
20. Mean platelet volume and risk of thrombotic and bleeding complications in patients with Philadelphia chromosome negative myeloproliferative neoplasms.
Krashin E; Cohen O; Pereg D; Lishner M; Leader A
Blood Coagul Fibrinolysis; 2018 Apr; 29(3):288-293. PubMed ID: 29474204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
